Investigational Drug Information for Dapansutrile
✉ Email this page to a colleague
What is the development status for investigational drug Dapansutrile?
Dapansutrile is an investigational drug.
There have been 7 clinical trials for Dapansutrile.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2022.
The most common disease conditions in clinical trials are Syndrome, COVID-19, and Gout. The leading clinical trial sponsors are Olatec Therapeutics LLC, Merck Sharp & Dohme Corp., and April Salama, M.D.
Summary for Dapansutrile
US Patents | 0 |
International Patents | 26 |
US Patent Applications | 41 |
WIPO Patent Applications | 22 |
Japanese Patent Applications | 7 |
Clinical Trial Progress | Phase 1 (2022-12-01) |
Vendors | 38 |
Recent Clinical Trials for Dapansutrile
Title | Sponsor | Phase |
---|---|---|
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | European Union (Horizon Europe Programme) | Phase 2 |
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | Olatec Therapeutics LLC | Phase 2 |
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | State Secretariat for Education Research and Innovation, Switzerland | Phase 2 |
Clinical Trial Summary for Dapansutrile
Top disease conditions for Dapansutrile
Top clinical trial sponsors for Dapansutrile
US Patents for Dapansutrile
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dapansutrile
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Dapansutrile | Australia | AU2011344030 | 2030-12-15 | ⤷ Sign Up |
Dapansutrile | Brazil | BR112013014583 | 2030-12-15 | ⤷ Sign Up |
Dapansutrile | Canada | CA2820625 | 2030-12-15 | ⤷ Sign Up |
Dapansutrile | China | CN103260613 | 2030-12-15 | ⤷ Sign Up |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |